Metabolism - Clinical and Experimental
Volume 46, Issue 4 , Pages 370-373, April 1997

Glutamine and arginine metabolism in tumor-bearing rats receiving total parenteral nutrition☆☆

  • Shogo Yoshida

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Shogo Yoshida, MD, First Department of Surgery, Kurume University, School of Medicine, 67 Asahi-machi, Kurume-shi, Fukuoka, 830, Japan.
    • First Department of Surgery, School of Medicine, Kurume University, Fukuoka, Japan
    • Pharmacology Research Laboratory, Taiho Pharmaceutical, Tokushima, Japan
  • ,
  • Nobuya Ishibashi

      Affiliations

    • First Department of Surgery, School of Medicine, Kurume University, Fukuoka, Japan
    • Pharmacology Research Laboratory, Taiho Pharmaceutical, Tokushima, Japan
  • ,
  • Toshihiro Noake

      Affiliations

    • First Department of Surgery, School of Medicine, Kurume University, Fukuoka, Japan
    • Pharmacology Research Laboratory, Taiho Pharmaceutical, Tokushima, Japan
  • ,
  • Yuichirou Shirouzu

      Affiliations

    • First Department of Surgery, School of Medicine, Kurume University, Fukuoka, Japan
    • Pharmacology Research Laboratory, Taiho Pharmaceutical, Tokushima, Japan
  • ,
  • Toshinori Oka

      Affiliations

    • First Department of Surgery, School of Medicine, Kurume University, Fukuoka, Japan
    • Pharmacology Research Laboratory, Taiho Pharmaceutical, Tokushima, Japan
  • ,
  • Kazuo Shirouzu

      Affiliations

    • First Department of Surgery, School of Medicine, Kurume University, Fukuoka, Japan
    • Pharmacology Research Laboratory, Taiho Pharmaceutical, Tokushima, Japan

Received 11 June 1996; accepted 22 October 1996.

Abstract 

Arginine supplementation increases glutamine levels in muscle and plasma. Since glutamine production is increased in catabolic states, these observations prompted us to investigate whether the flux of arginine to glutamine was increased in tumor-bearing (TB) rats, and we measured the synthesis rate of glutamine from arginine in control versus TB rats receiving standard total parenteral nutrition (TPN) solution. Male Donryu rats (N = 36; body weight, 200 to 225 g) were divided into two groups, control and TB rats. Yoshida sarcoma cells (1 × 106) were inoculated into the back of the rats (n = 18) subcutaneously on day 0. The rats were given free access to water and rat chow. On day 5, all animals, including non-TB rats (n = 18), were catheterized at the jugular vein and TPN was begun. On day 10, TPN solution containing either U-14C-glutamine (2.0 μCi/h) or U-14C-arginine (2.0 μCi/h) was infused as a 6-hour constant infusion. At the end of the isotope infusion, plasma was collected to determine the glutamine production rate in rats receiving U-14C-glutamine, and the ratio of specific activity of glutamine to specific activity of arginine was measured in rats receiving U-14C-arginine. Only 2 g tumor caused a decrease in glutamine levels and an increase in glutamine and arginine production. The low flux rate of arginine to glutamine was observed in control rats (Arg to Gln, 41.0 ± 11.9 μmol/kg/h). On the other hand, TB caused a significant increase in Arg to Gln compared with the control (213.3 ± 66.1 μmol/kg/h, P < .01 v control). An increase in the flux rate of Arg to Gln was associated with an enhancement in the ratio of specific activity of ornithine to specific activity of arginine in TB rats (control 51.5% ± 10.9% v 77.4% ± 8.9%, P < .05). We conclude that (1) glutamine and arginine metabolism is altered with very small tumors, (2) although the flux of Arg to Gln was increased in TB and rats, the small increase in Arg to Gln cannot explain the observed large increase in Gln production.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by the Otsuka Pharmaceutical Research Fund and the Kurume University Research Fund.

☆☆ Presented at the Twentieth Annual Meeting of the American Society for Parenteral and Enteral Nutrition, Washington, DC, January 15, 1996.

PII: S0026-0495(97)90049-4

Metabolism - Clinical and Experimental
Volume 46, Issue 4 , Pages 370-373, April 1997